Safety and clinical outcome of tamoxifen in Duchenne muscular dystrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and clinical outcome of tamoxifen in Duchenne muscular dystrophy

Published:2021-09 Issue:9 Volume:31 Page:803-813
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Tsabari Reuven,Simchovitz Elana,Lavi Eran,Eliav Osnat,Avrahami Ran,Ben-Sasson Shmuel,Dor Talya

Publisher

Elsevier BV

Subject

Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health

Reference33 articles.

1. Muscular dystrophies;Mercuri;Lancet,2019

2. Absence of dystrophin disrupts skeletal muscle signaling: roles of ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy;Allen;Physiol Rev,2016

3. The pathogenesis and therapy of muscular dystrophies;Guiraud;Annu Rev Genomics Hum Genet,2015

4. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study;McDonald;Muscle Nerve,2013

5. Pulmonary function and clinical correlation in DMD;Mayer;Paediatr Respir Rev,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of 2097 patients with dystrophinopathy based on a database from 2011 to 2021;Orphanet Journal of Rare Diseases;2024-08-24

2. Cancer Therapy and Exercise Intolerance: The Heart Is But a Part;JACC: CardioOncology;2024-08

3. The unconditioned fear response in vertebrates deficient in dystrophin;Progress in Neurobiology;2024-04

4. Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading;Journal of Neuromuscular Diseases;2024-01-02

5. Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet Neurology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3